69.46EUR-1.45%Mkt Cap: 3.51B EURP/E: 26.79Last update: 2026-05-14
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiag…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)26.79
P/E (Forward)15.88
PEG1.66
P/B2.36
P/S3.00
EV/EBITDA—
EV/Revenue—
EPS (TTM)2.64
EPS (Forward)4.44
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF342.76M EUR
CapEx (TTM)137.68M EUR
Net Debt/EBITDA—
Net Debt—
Technical
SMA 5062.57 (+11.0%)
SMA 20070.38 (-1.3%)
Beta0.66
S&P 52W Chg24.23%
Avg Vol (30d)335.74K
Avg Vol (10d)414.08K
Technical Indicators
RSI (14)66.7
MACD1.5691
MACD Signal0.3308
MACD Hist.+1.2383
BB Upper70.26 EUR
BB Middle62.69 EUR
BB Lower55.12 EUR
BB Width24.15%
ATR (14)2.769 EUR
Vol Ratio (20d)1.12x
52W Range
52.3439% of range96.30
52W High96.30 EUR
52W Low52.34 EUR
Profitability
Gross Margin64.72%
EBITDA Margin30.30%
Profit Margin13.02%
Oper. Margin20.56%
ROE9.82%
ROA5.42%
Revenue Growth-8.30%
Earnings Growth—
Balance Sheet
Debt/Equity0.50
Current Ratio—
Quick Ratio—
Book Value/Sh29.90 EUR
Cash/Share—
Dividends
Fwd Div Rate1.300 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.85%
5Y Avg Yield1.10%
Payout Ratio45.55%
Ex-Div DateMay 18, 2026
Pay Date—
Ownership
Shares Out.49.81M
Float23.19M
Insiders57.56%
Institutions16.48%
Analyst Consensus
Rating2.6 (Hold)
Target (Mean)69.86 EUR
Target Range58.00 EUR – 81.30 EUR
# Analysts12
Company
Market Cap3.51B EUR
Enterprise Value—
Revenue (TTM)1.17B EUR
Gross Profit773.47M EUR
Net Income (TTM)155.62M EUR
Revenue/Share22.06 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.2K
Last Price69.46 EUR
CountryIT
SectorHealthcare
IndustryDiagnostics & Research
ISINIT0003492391